We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUNA
6801
DELISTED
Luna Innovations Incorporated
LUNA
$0 ﹤0.01%
+9
New +$79
GDSTU
6802
DELISTED
Goldenstone Acquisition Limited Units
GDSTU
-2
Closed
CPTNW
6803
DELISTED
Cepton, Inc. Warrant
CPTNW
$0 ﹤0.01%
192
MARXU
6804
DELISTED
Mars Acquisition Corp. Unit
MARXU
$0 ﹤0.01%
+16
New +$164
GHIXU
6805
DELISTED
Gores Holdings IX, Inc. Unit
GHIXU
-300
Closed -$3K
BLEU
6806
DELISTED
bleuacacia ltd Class A Ordinary Shares
BLEU
-28
Closed
QOMOU
6807
DELISTED
Qomolangma Acquisition Corp. Unit
QOMOU
-200
Closed -$2K
AEAEU
6808
DELISTED
AltEnergy Acquisition Corp Unit
AEAEU
$0 ﹤0.01%
1
IVCBU
6809
DELISTED
Investcorp Europe Acquisition Corp I Unit
IVCBU
$0 ﹤0.01%
+25
New +$263
AVHIU
6810
DELISTED
Achari Ventures Holdings Corp I Unit
AVHIU
$0 ﹤0.01%
32
MBTCU
6811
DELISTED
Nocturne Acquisition Corporation Unit
MBTCU
-119
Closed -$1K
YGF
6812
DELISTED
YanGuFang International Group Co., Ltd. Ordinary Shares
YGF
$0 ﹤0.01%
+37
New +$142
PEPLU
6813
DELISTED
PepperLime Health Acquisition Corporation Unit
PEPLU
-7,548
Closed -$76K
NBO
6814
DELISTED
Neuberger Berman New York Municipal Fund Inc.
NBO
-100
Closed -$1K
YELL
6815
DELISTED
Yellow Corporation Common Stock
YELL
$0 ﹤0.01%
7
-2,303
-100% -$6.14K
JRO
6816
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
-12
Closed
AAWW
6817
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
-327
Closed -$33K
PTOCU
6818
DELISTED
Pine TechnologYES Acquisition Corp. Unit
PTOCU
-74
Closed -$1K
REV
6819
DELISTED
Revlon, Inc.
REV
-227
Closed
NTP
6820
DELISTED
Nam Tai Property Inc.
NTP
-389
Closed -$1K
MTL
6821
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
-3,534
Closed
SVA
6822
DELISTED
Sinovac Biotech, Ltd
SVA
-424
Closed
IMH
6823
DELISTED
Impac Mortgage Holdings Inc.
IMH
$0 ﹤0.01%
707
+13
+2% +$5
TSRI
6824
DELISTED
TSR Inc. New
TSRI
$0 ﹤0.01%
52
-478
-90% -$4.07K
OPT
6825
DELISTED
Opthea Limited American Depositary Shares
OPT
$0 ﹤0.01%
+1
New +$5

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.